Stylus Medicine, Inc. ("Stylus"), a biotechnology company dedicated to developing transformative in vivo genetic medicines, today emerges from stealth with $85 million in financing. Stylus' funding ...

Fusion energy startup Realta Fusion today announced an oversubscribed $36 million Series A round to bring its compact, scalable, modular magnetic mirror fusion technology closer to ...

Somite AI, a TechBio company leveraging foundation models and proprietary AI to accelerate human cell therapy development, closed its Series A funding round, raising more than $47 million. The round ...

Eight Sleep Inc., a startup known for its high-tech, temperature-controlled mattress covers and systems, released an expanded ...

Stylus will use the Eli Lilly and J&J-backed funds to advance its in vivo genetic medicines platform and develop its pipeline ...

Some fusion companies might be hitting a rough patch, but Realta Fusion is bucking the trend with a new fundraising round it ...

Stylus Medicine is unsheathing, penning a mission to develop next-gen in vivo genetic medicines with $85 million in hand, ...

Rep. Gerald Connolly, ranking member of the U.S. House Oversight Committee, has initiated an investigation into whether ...

The probe comes in the wake of a ProPublica investigation that revealed the General Services Administration was eyeing a tech ...

Investors have reaped billions of dollars in gains from backing database software firms Snowflake and Databricks. Now venture ...

Former Palantir Technologies Inc. adviser Jacob Helberg plans to retain investments in dozens of artificial intelligence, ...

The game industry’s motto for all of last year was "survive til 2025." And in some respects, that wasn't just wishful ...